VPS4A and colorectal carcinoma: The key findings of the study came next, where it was demonstrated that by knocking down expression of VPS4A in a CRC cell line, its function could be modulated and ultimately sensitize the cells to CRC drug treatment, significantly in the case of Oxa, with some sensitization also evident to a lesser extent for Iri and 5-FU.